Corcept Therapeutics Return on Net Operating Assets Analysis

Corcept Therapeutics, Inc. (CORT)

46.02 +0.94 (+2.09%) USD | NASDAQ | Apr 24, 13:07

View Return on Net Operating Assets for CORT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Merck & Co., Inc.	Upgrade
Terns Pharmaceuticals, Inc.	Upgrade
Integer Holdings Corp.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Catalyst Pharmaceuticals, Inc.	Upgrade

Return on Equity	Upgrade
Return on Assets	Upgrade
Return on Invested Capital	Upgrade
Profit Margin (Quarterly)	Upgrade
Gross Profit Margin (Quarterly)	Upgrade
Operating Margin (Quarterly)	Upgrade